Explore
Validate
Learn17858-1-AP
antibody from Proteintech Group
Targeting: MSR1
CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17858-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MSR1 antibody
- Antibody type
- Polyclonal
- Description
- MSR1 antibody (Cat. #17858-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Low-intensity pulsed ultrasound responsive phase-change nanoparticles loaded with rapamycin for targeted therapy of atherosclerotic plaques.
MLN4924 inhibits macrophage foam cell formation by enhancing autophagy and regulating metabolic phenotype.
Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation.
The mechanism of low molecular weight fucoidan-incorporated nanofiber scaffolds inhibiting oral leukoplakia via SR-A/Wnt signal axis.
Mechanism of ozone alleviation of malignant ascites in hepatocellular carcinoma through the inhibition of neutrophil extracellular traps.
Inclisiran inhibits oxidized low-density lipoprotein-induced foam cell formation in Raw264.7 macrophages via activating the PPARĪ³ pathway.
Wang D, Zhang X, Tang L, Wang S, He Y, Liu J, Wang Y, Zhang S, Lai J, Lyu G
RSC advances 2026 Jan 2;16(2):1078-1094
RSC advances 2026 Jan 2;16(2):1078-1094
MLN4924 inhibits macrophage foam cell formation by enhancing autophagy and regulating metabolic phenotype.
Xing L, Bu Y, Shi J, Liu J, Hu F, Zhang M, Fan J
Lipids in health and disease 2025 Oct 2;24(1):307
Lipids in health and disease 2025 Oct 2;24(1):307
Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation.
Yang Y, Chen Z, Song D, Wu J, Wang J, YouyouYan
International immunopharmacology 2025 Apr 24;153:114553
International immunopharmacology 2025 Apr 24;153:114553
The mechanism of low molecular weight fucoidan-incorporated nanofiber scaffolds inhibiting oral leukoplakia via SR-A/Wnt signal axis.
Xu M, Sun Y, Cong B, Zhang X, Li Z, Liu Y, Geng L, Qin Q, Wu Y, Gao M, Wang W, Wang Y, Xu Y
Frontiers in pharmacology 2024;15:1397761
Frontiers in pharmacology 2024;15:1397761
Mechanism of ozone alleviation of malignant ascites in hepatocellular carcinoma through the inhibition of neutrophil extracellular traps.
Han F, Guo J, Mu M, Bian K, Cui Z, Duan Q, Ma J, Jin L, Liu W, Chen F
PNAS nexus 2023 Sep;2(9):pgad280
PNAS nexus 2023 Sep;2(9):pgad280
Inclisiran inhibits oxidized low-density lipoprotein-induced foam cell formation in Raw264.7 macrophages via activating the PPARĪ³ pathway.
Wang Z, Chen X, Liu J, Wang Y, Zhang S
Autoimmunity 2022 Jun;55(4):223-232
Autoimmunity 2022 Jun;55(4):223-232
No comments: Submit comment
No validations: Submit validation data